Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Share This Author
Atezolizumab for First‐Line Treatment of Metastatic Nonsquamous NSCLC
- M. Socinski, R. Jotte, M. Reck
- MedicineThe New England journal of medicine
- 4 June 2018
TLDR
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): a randomised phase III trial
- Edward S. Kim, V. Hirsh, J. Douillard
- Medicine, BiologyThe Lancet
- 22 November 2008
Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a…
- M. Socinski, I. Bondarenko, M. Renschler
- MedicineJournal of clinical oncology : official journal…
- 10 June 2012
TLDR
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs.
- M. Kris, Bruce E. Johnson, P. Bunn
- MedicineJAMA
- 21 May 2014
TLDR
First‐Line Nivolumab in Stage IV or Recurrent Non–Small‐Cell Lung Cancer
- D. Carbone, M. Reck, M. Socinski
- MedicineThe New England journal of medicine
- 21 June 2017
TLDR
Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial.
- J. Douillard, F. Shepherd, Edward S. Kim
- Biology, MedicineJournal of clinical oncology : official journal…
- 10 February 2010
TLDR
Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation
- M. Wilkerson, Xiaoying Yin, D. Hayes
- Biology, MedicinePloS one
- 10 May 2012
TLDR
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label,…
- N. Thatcher, F. Hirsch, M. Socinski
- MedicineThe Lancet. Oncology
- 1 July 2015
Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised,…
- M. Reck, T. Mok, M. Socinski
- Medicine, BiologyThe Lancet. Respiratory medicine
- 1 May 2019
Systematic review evaluating the timing of thoracic radiation therapy in combined modality therapy for limited-stage small-cell lung cancer.
- D. Fried, D. Morris, M. Socinski
- Medicine, BiologyJournal of clinical oncology : official journal…
- 1 December 2004
TLDR
...
1
2
3
4
5
...